MICHAEL THOMAS HENDERSON - Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by MICHAEL THOMAS HENDERSON since 28 Feb 2025

Holdings reported by MICHAEL THOMAS HENDERSON for Spyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 168,606 $5,523,583 $32.76 21 Jan 2026 Direct
Stock Option (Right to Buy) 25,000 29 May 2025 Direct Common Stock

Transactions reported by MICHAEL THOMAS HENDERSON for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.